|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 11400 TOMAHAWK CREEK PARKWAY |
Address2 |
|
| City | LEAWOOD |
State | KS |
Zip Code | 66211-2672 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1342-12
|
||||||||
|
6. House ID# 321800000
|
||||||||
| TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Lisa R. Westergaard |
Date | 4/19/2016 4:34:14 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
HR 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act: Opposing provisions that would have repealed elements of the Affordable Care Act.
No Bill No.- FY2017 budget request for AHRQ, Title VII 747, Nat'l Health Service Corps: Federal spending priorities to support workforce, research; AAFP spending priorities to support workforce, research.
No Bill No.- FY2017 budget request for HHS: adequate funding of AAFP federal budget priorities.
No Bill No.- FY 2017 appropriation for AHRQ: Restore AHRQ funding.
No Bill No.- President's Budget: Supporting funding for prevention of prescription drug abuse, for research on Zika virus, and enhanced federal matching for Medicaid expansion.
No Bill No.- Site-Neutral Payment for Physicians: Supporting Site neutral payment policies for Medicare and Medicaid.
No Bill No.- Adult Vaccines: Adult Vaccines Report Language.
No Bill No.- Gun Violence/Appropriations: Encouraging Gun Violence Prevention Research; CDC Gun Violence Research.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
HR 4223 - restore graduate & professional student debt relief - POST GRAD Act
FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to fix problem caused by "rotators" who establish low caps and PRAs.
No Bill No.-Graduate Medical Education: Advocate for solution to VACAA Expansion slots - how to fill them with more family medicine residents.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: Maintain the sustainability of the THCGME program.
No Bill No.- FY2017 budget request for AHRQ, Title VII 747, Nat'l Health Service Corps: Federal spending priorities to support workforce, research; AAFP spending priorities to support workforce, research.
No Bill No.- FY2017 appropriations for HRSA: Title VII Primary Care Training & NHSC.
No Bill No. - Graduate Medical Education reforms: THCGME permanence, support for physicians reentering practice, & fix for cap harm of residents rotating thru hospitals.
No Bill No. - FY2017 appropriations for AHRQ, Title VII 747, Natl Health Service Corps: AAFP spending priorities to support workforce, research.
No Bill No. - FY2017 budget request for HHS: Adequate finding of AAFP federal budget priorities.
No Bill No. - Prevention and Treatment of Concussions - Supporting Congressional review of how federal agencies can help physicians & patients prevent and treat concussions and head trauma.
No Bill No. - Graduate Medical Education - Encouraging Teaching Health Centers Reauthorization.
No Bill No. - Graduate Medical Education - Explain and advocate for AAFP's policy proposals on GME.
No Bill No. - Congressional Primary Care Caucus - Urge members to join the Caucus and support Primary Care to achieve the triple aim in health care.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Sonya |
Clay |
|
|
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 142 Child Nicotine Poisoning Prevention Act: Supporting requirements for child resistant packaging for liquid nicotine.
S. 524/HR 953 - Comprehensive Addiction and Recovery Act: Support state prescription drug monitoring, treatment, naloxone, take-backs & partial fill; Supporting drug monitoring programs & interstate exchange of data, and opposing mandatory professional education for prescribing physicians; provided AAFP's position on the CDC prescription drug rule; and Partial Fill Bill.
S. 2511 - Improving Health Information Technology Act: Supporting interoperability and the prevention of information blocking.
HR 6 - Antibiotics/Infectious Disease - Cures and Innovations Legislation: Cures, Antibiotics.
HR 2017 - Common Sense Nutrition Disclosure Act: Supporting FDA menu labeling requirements.
HR 2646/S 1945 - Mental Health Reform: Urged members to support Primary Care and Mental Health policies; Letter to Senate HELP.
HR 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act: Opposing provisions that would have repealed elements of the Affordable Care Act.
HR 4470 - Safe Drinking Water Improved Compliance Act: Supporting requirement that public water utilities notify customers of excessive lead.
HR 4725 - Common Sense Budget Savings Act: Letter to E&C with concerns about cutes to CHIP, Medicaid, and the Prevention fund.
HR 4771 - Medical Liability Reform: Support Help Efficient, Accessible. Low Cost. Timely Health Care "HEALTH" Act.
No Bill No.- Health IT: Advocate for Introduction of a Bill to reduce Meaningful Use Reporting Period for 2016 to 90 days.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to fix problem caused by "rotators" who establish low caps and PRAs.
No Bill No. - Physician Payment Reform: Work with House Committee on Energy and Commerce on oversight of MACRA implementation; Advocate for reforms to the Senate Finance Committee, Chronic Care Working Group; Advocate for reforms to Stark Law to smooth pathway for MACRA implementation; Advise members and committees of jurisdiction on the impacts on family medicine of certain policies under development regarding telemedicine; Advise E&C Committee on AAFP's position on the CMS Part B Drug Demonstration.
No Bill No.-Graduate Medical Education: Advocate for solution to VACAA Expansion slots - how to fill them with more family medicine residents.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: Maintain the sustainability of the THCGME program.
No Bill No. - HHS External Opioid Working Group: Meeting AAFP commitment to curb prescription opioid abuse.
No Bill No. - Encourage House members to join Primary Care Caucus: Increase membership of the Primary Care Caucus.
No Bill No. - FY2017 budget proposal on the Prescription Opioid & Heroin Epidemic; Family medicine's role in curbing Rx abuse, drug treatment.
No Bill No.- FY2017 budget request for AHRQ, Title VII 747, Nat'l Health Service Corps: Federal spending priorities to support workforce, research; AAFP spending priorities to support workforce, research.
No Bill No.- FY2017 appropriations for HRSA: Title VII Primary Care Training & NHSC.
No Bill No. - Graduate Medical Education reforms: THCGME permanence, support for physicians reentering practice, & fix for cap harm of residents rotating thru hospitals.
No Bill No. - FY2017 appropriations for AHRQ, Title VII 747, Natl Health Service Corps: AAFP spending priorities to support workforce, research.
No Bill No. - Affordable Care Act review on health care access: AAFP Healthcare for all.
No Bill No. - FY2017 appropriations for AHRQ, Restore AHRQ funding.
No Bill No. - Letter on draft 2017 market place: MMM Marketplace plan coverage.
No Bill No. - Smoke-free housing: Smoke-free policy in public housing.
No Bill No. - Meaningful use ending: Statement about end of meaningful use.
No Bill No. - Opioid prescribing: How primary care physicians prescribe.
No Bill No. - Measures in MACRA: Which measures MIPS and APM pathways should use.
No Bill No. - Episode groups in MACRA: How episode groups are used in MIPS and APMs.
No Bill No. - Measures in MACRA AHRQ: Which measures should be used.
No Bill No. - New tobacco products: Further FDA oversight over markets.
No Bill No. - Nomiatning FPs to MedPAC: Nominating FPs to MedPAC.
No Bill No. - CMS on TCM code: Improvements to TCM code.
No Bill No. - MU issues with CMS - Further meaningful use concerns.
No Bill No. - ACO proposed rule: Response to ACO proposed rule.
No Bill No. - CMS on qualified data entities: How MACRA allows entities to study CMS data.
No Bill No. - CMS on rising Drug Costs: Concerns with rising Part B and D costs.
No Bill No. - Smoke Free Public Housing: Supporting the proposed HUD regulation on smoke-free public housing.
No Bill No. - Prevention and Treatment of Concussions - Supporting Congressional review of how federal agencies can help physicians & patients prevent and treat concussions and head trauma.
No Bill No. - Prevention of Gun Violence: Supporting HHS rule permitting disclosure of those who for mental health reasons should not have gun permits.
No Bill No. - Meaningful Use: Recommending postponement of Meaningful Use Stage 3 until current system is accepted.
No Bill No. - Prevention of Prescription Drug Abuse: Supporting drug monitoring programs and interstate exchange of data.
No Bill No.- President's Budget: Supporting funding for prevention of prescription drug abuse, for research on Zika virus, and enhanced federal matching for Medicaid expansion.
No Bill No.- Chronic Care Management: Supporting cost-effective solutions for Medicare patients with multiple chronic diseases.
No Bill No. - Medicare Part B Drug Pricing: Supporting effort to test better methods to pay for drugs administered in the physician's office.
No Bill No. - Concussions Round table/House E&C Committee: Concussion Meetings.
No Bill No. - Adult Vaccines: Adult vaccines Report Language.
No Bill No. - Health IT: Urging members to introduce Meaningful Use flexibility legislation, Meetings on telehealth.
No Bill No. - Primary Care: Urged members to join the Primary Care Coalition.
No Bill No. - Graduate Medical Education: Encouraging Teaching Health Centers Reauthorization.
No Bill No. - MACRA - House E&C Hearing: MACRA Implementation Hearing.
No Bill No. - Teaching Health Center Graduate Medical Education: Maintain the sustainability of the THCGME program.
No Bill No.- FY2016 budget request for AHRQ, Title VII 747, Nat'l Health Service Corps: Federal spending priorities to support workforce, research; AAFP spending priorities to support workforce, research.
No Bill No. - Graduate Medical Education: Explain and advocate for AAFP's policy proposals on GME.
No Bill No. - Congressional Primary Care Caucus: Urge Members to join the caucus and support primary care to achieve the triple aim in health care.
No Bill No. - Gun Violence/Appropriations: CDSC Gun Violence research.
No Bill No. - Health Insurance Marketplace Issues & Provider Involvement with Patient Enrollment.
No Bill No. - Childrens Health Insurance: CHIP Medicaid.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), White House Office, Office of Natl Drug Control Policy (NDCP), Health Resources & Services Administration (HRSA), Housing & Urban Development - Dept of (HUD), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Agency for Healthcare Research & Quality (AHRQ), Food & Drug Administration (FDA), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Shannon |
Morey |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 2646/S 1945 - Mental Health Reform: Urged members to support Primary Care and Mental Health policies; Letter to Senate HELP.
HR 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act: Opposing provisions that would have repealed elements of the Affordable Care Act.
No Bill No.- Health IT: Advocate for Introduction of a Bill to reduce Meaningful Use Reporting Period for 2016 to 90 days.
No Bill No.-Graduate Medical Education: Advocate for introduction of a bill to fix problem caused by "rotators" who establish low caps and PRAs.
No Bill No. - Physician Payment Reform: Work with House Committee on Energy and Commerce on oversight of MACRA implementation; Advocate for reforms to the Senate Finance Committee, Chronic Care Working Group; Advocate for reforms to Stark Law to smooth pathway for MACRA implementation; Advise members and committees of jurisdiction on the impacts on family medicine of certain policies under development regarding telemedicine; Advise E&C Committee on AAFP's position on the CMS Part B Drug Demonstration.
No Bill No. - Teaching Health Center Graduate Medical Education permanence: Maintain the sustainability of the THCGME program.
No Bill No. - HHS External Opioid Working Group: Meeting AAFP commitment to curb prescription opioid abuse.
No Bill No. - Encourage House members to join Primary Care Caucus: Increase membership of the Primary Care Caucus and support Primary Care to achieve the triple aim in health care.
No Bill No.- FY2017 appropriations for HRSA: Title VII Primary Care Training & NHSC.
No Bill No. - Graduate Medical Education reforms: THCGME permanence, support for physicians reentering practice, & fix for cap harm of residents rotating thru hospitals.
No Bill No. - FY2017 appropriations for AHRQ, Title VII 747, Natl Health Service Corps: AAFP spending priorities to support workforce, research.
No Bill No. - Opioid prescribing guidelines: Support evidence-based practice guidelines for Prescribing Opioids for chronic pain.
No Bill No. - Letter on draft 2017 market place: MMM Marketplace plan coverage.
No Bill No. - Measures in MACRA: Which measures MIPS and APM pathways should use.
No Bill No. - Episode groups in MACRA: How episode groups are used in MIPS and APMs.
No Bill No. - Measures in MACRA AHRQ: Which measures should be used.
No Bill No. - Nomiatning FPs to MedPAC: Nominating FPs to MedPAC.
No Bill No. - CMS on TCM code: Improvements to TCM code.
No Bill No. - MU issues with CMS - Further meaningful use concerns.
No Bill No. - ACO proposed rule: Response to ACO proposed rule.
No Bill No. - CMS on qualified data entities: How MACRA allows entities to study CMS data.
No Bill No.- Chronic Care Management: Supporting cost-effective solutions for Medicare patients with multiple chronic diseases.
No Bill No. - Medicare Part B Drug Pricing: Supporting effort to test better methods to pay for drugs administered in the physician's office.
No Bill No. - Site Neutral payment for Physicians: Supporting site-neutral payment policies for Medicare and Medicaid.
No Bill No. - Adult Vaccines: Adult vaccines report language.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), White House Office, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Agency for Healthcare Research & Quality (AHRQ), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Kevin |
Burke |
|
Deputy Assistant at HHS |
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
HR 4725 - Common Sense Budget Savings Act: Letter to E&C with concerns about cutes to CHIP, Medicaid, and the Prevention fund.
S. 142 Child Nicotine Poisoning Prevention Act: Supporting requirements for child-resistant packaging for liquid nicotine.
No Bill No - Smoke Free Public Housing: Supporting the proposed HUD regulation on smoke-free public housing.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Housing & Urban Development - Dept of (HUD)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
No Bill No.-Adult Vaccines: Adult Vaccines Report Language.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
S 524/HR 953 - Comprehensive Addiction and Recovery Act: Supporting drug monitoring programs & interstate exchange of data, and opposing mandatory professional education for prescribing physicians.
No Bill No.-Prescription Drug Abuse: Supporting drug monitoring programs and interstate exchange of data.
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
No Bill No. - Prevention of Gun Violence: Supporting HHS rule permitting disclosure of those, who for mental health reasons, should not have gun permits.
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
HR 2017 - Common Sense Nutrition disclosure act: Supporting FDA on menu labeling requirements.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
s. 524 - Comprehensive Addiction and Recovery Act: Support state prescription drug monitoring, treatment, naloxone, take-backs and partial fill.
No Bill No - HHS External Opioid Working Group: Meeting AAFP commitment to curb prescription opioid abuse.
No Bill No - Family Medicine Congressional Conference Speaker request: Speaker for FMCC session on curbing prescription drug abuse.
No Bill No. - FY2017 budget proposal on the Prescription Opioid & Heroin Epidemic; Family medicine's role in curbing Rx abuse, drug treatment.
No Bill No - Opioid prescribing guidelines: Support evidence based practice guidelines for Prescribing Opioids for Chronic pain.
17. House(s) of Congress and Federal agencies Check if None
Office of Natl Drug Control Policy (NDCP), Health & Human Services - Dept of (HHS), White House Office, U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst & Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
HR 4771 Medical Liability Reform: Support Help Efficient, Accessible, Low-cost, Timely Healthcare "HEALTH" Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOU
16. Specific lobbying issues
No Bill No - Smoke Free Public Housing: Supporting the proposed HUD regulation on smoke-free public housing.
17. House(s) of Congress and Federal agencies Check if None
Housing & Urban Development - Dept of (HUD), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TEC
16. Specific lobbying issues
S. 2511 Improving Health Information Technology Act: Supporting inoperability and the prevention of information blocking.
No Bill No - Meaningful Use: Recommending postponement of Meaningful Use Stage 3 until current system is accepted.
No Bill No - Health IT: Urging members to introduce Meaningful Use flexibility legislation, Meetings on telehealth.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS. |
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
HR 4470 - Safe Drinking Water Improved Compliance Act: Supporting requirement that public water utilities notify customers of excessive lead.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kevin |
Burke |
|
Deputy Assistant Secretary at HHS. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SPO
16. Specific lobbying issues
No Bill No - Concussions round table/House E&C Committee: Concussion meetings.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
HR 2646/S 1945 - Mental Health Reform: Urged members to support Primary Care and Mental Health policies; Letter to Senate HELP.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
S. 524 - Substance Use/Drugs: provided AAFP's position on the CDC prescription drug rule; and Partial Fill Bill.
No Bill No - Concussions round table/House E&C Committee: Concussion meetings.
No Bill No.- Gun Violence/Appropriations: Encouraging Gun Violence Prevention Research; CDC Gun Violence Research.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |